Biotrial

Solutions & Services
Solutions & Services
Preclinical

Safety

Efficacy

PK Studies

Model Development

Core Lab

Central EEG & Polysomnography

CNS Testing

Cardiac Safety & ECG

QT Investigations

Medical Imaging

Clinical

Phase 1 Healthy Volunteers

Specialized Phase 1 studies

Oncology Trial Management

Patient Trial Management

Clinical Monitoring

Pharmacovigilance & Medical Monitoring

Pharmaceutical Affairs

Regulatory Affairs

Bioanalysis

Non-GLP & Discovery Services

Method Development & Method Transfer

GLP Preclinical Sample Analysis

Quantitative Bioanalysis using LC-MS MS

Sample Management & Storage

Biometrics

EDC (Electronic Data Capture)

Data Management

Biostatistics

Medical Writing
Therapeutic Areas
About Us
About Us
About Us

History

Mission

Our locations

Biotrial

Contact

Solutions & Services Ouvrir
- Preclinical
  - Safety
  - Efficacy
  - PK Studies
  - Model Development
- Core Lab
  - Central EEG & Polysomnography
  - CNS Testing
  - Cardiac Safety & ECG
  - QT Investigations
  - Medical Imaging
- Clinical
  - Phase 1 Healthy Volunteers
  - Specialized Phase 1 studies
  - Oncology Trial Management
  - Patient Trial Management
  - Clinical Monitoring
  - Pharmacovigilance & Medical Monitoring
  - Pharmaceutical Affairs
  - Regulatory Affairs
- Bioanalysis
  - Non-GLP & Discovery Services
  - Method Development & Method Transfer
  - GLP Preclinical Sample Analysis
  - Quantitative Bioanalysis using LC-MS MS
  - Sample Management & Storage
- Biometrics
  - EDC (Electronic Data Capture)
  - Data Management
  - Biostatistics
  - Medical Writing
Therapeutic Areas
About Us Ouvrir

English Canadian

Corporate

Biotrial 2023 annual newsletter

From breakthrough MESHCAP project advancements to our commitment to growth through the Boost 2030 plan, Biotrial’s 2023 was a testament to excellence and innovation.

Complete the form to download the 2023 newsletter

Back home

Back to news

Participate in a clinical trial

Volunteer in France

Volunteer in USA

Contact

Scroll to top